Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 2 2

Status

Unknown 5Completed 4Active not recruiting 3Withdrawn 2Suspended 2Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Head & Neck 1

Conditions

Oropharyngeal Neoplasms 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Adenocarcinoma of Lung 1

Interventions

Radiotherapy 2Radiation 2Nivolumab 2Magnetic Resonance Spectroscopy 2lenvatinib 1Specimen Handling 1Sorafenib 1Platinum 1Photochemotherapy 1Oxycodone 1NUC-1031 1Ketorolac 1Ketamine 1Ipilimumab 1Gemcitabine 1Folfox protocol 1Cisplatin 1CTLA-4 Antigen 1Biopsy 1Acetaminophen 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Suspended × Radiation × Clear all
NCT04929041 2026-05-13

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

National Cancer Institute (NCI)

Phase 2/3 Suspended
427 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡